Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Stem Cell Therapy
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Recipient : Avra
Deal Size : Undisclosed
Deal Type : Merger
Details : The combined entity will focus on stem cell therapy, facial rejuvenation, hair rejuvenation, non-surgical hair restoration, protein rich plasma (PRP) injections, and anti-aging treatments.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
December 20, 2021
Lead Product(s) : Stem Cell Therapy
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Recipient : Avra
Deal Size : Undisclosed
Deal Type : Merger
LOOKING FOR A SUPPLIER?